Induction therapy for active lupus nephritis: mycophenolate mofetil versus cyclophosphamide

被引：0
|
作者：
Christian Burchardi
Detlef Schlöndorff
机构：
[1] Medizinische Poliklinik of Ludwig Maximilian University,
来源：
Nature Clinical Practice Nephrology | 2006年 / 2卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：314 / 315
页数：1
相关论文
共 50 条
  • [1] Induction therapy for active lupus nephritis:: mycophenolate mofetil versus cyclophosphamide -: Commentary
    Burchardi, Christian
    Schloendorff, Detlef
    NATURE CLINICAL PRACTICE NEPHROLOGY, 2006, 2 (06): : 314 - 315
  • [2] Induction therapy for active lupus nephritis: mycophenolate mofetil is superior to cyclophosphamide
    Jennifer R Elliott
    Susan Manzi
    Nature Clinical Practice Rheumatology, 2006, 2 : 354 - 355
  • [3] Induction therapy for active lupus nephritis: mycophenolate mofetil is superior to cyclophosphamide
    Elliott, Jennifer R.
    Manzi, Susan
    NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2006, 2 (07): : 354 - 355
  • [4] INDUCTION THERAPY FOR PEDIATRIC ONSET LUPUS NEPHRITIS : MYCOPHENOLATE MOFETIL VERSUS CYCLOPHOSPHAMIDE
    Eveillard, Laurye-anne
    Chbihi, Marwa
    Riller, Quentin
    Rabant, Marion
    Dehoux, Laurene
    Charbit, Marina
    Biebuyck, Nathalie
    Avramescu, Marina
    Bader-Meunier, Brigitte
    Boyer, Olivia
    PEDIATRIC NEPHROLOGY, 2021, 36 (10) : 3378 - 3378
  • [5] Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis
    Appel, Gerald B.
    Contreras, Gabriel
    Dooley, Mary Anne
    Ginzler, Ellen M.
    Isenberg, David
    Jayne, David
    Li, Lei-Shi
    Mysler, Eduardo
    Sanchez-Guerrero, Jorge
    Solomons, Neil
    Wofsy, David
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 20 (05): : 1103 - 1112
  • [6] Mizoribine versus mycophenolate mofetil or intravenous cyclophosphamide for induction treatment of active lupus nephritis
    Feng Xuebing
    Gu Fei
    Chen Weiwei
    Liu Yan
    Wei Hua
    Liu Lin
    Yin Songlou
    Da Zhanyun
    Sun Lingyun
    中华医学杂志(英文版), 2014, (21) : 3718 - 3723
  • [7] Mizoribine versus mycophenolate mofetil or intravenous cyclophosphamide for induction treatment of active lupus nephritis
    Feng Xuebing
    Gu Fei
    Chen Weiwei
    Liu Yan
    Wei Hua
    Liu Lin
    Yin Songlou
    Da Zhanyun
    Sun Lingyun
    CHINESE MEDICAL JOURNAL, 2014, 127 (21) : 3718 - 3723
  • [8] Induction Therapy for Pediatric Focal Proliferative Lupus Nephritis: Cyclophosphamide Versus Mycophenolate Mofetil
    Lau, Keith K.
    Ault, Bettina H.
    Jones, Deborah P.
    Butani, Lavjay
    JOURNAL OF PEDIATRIC HEALTH CARE, 2008, 22 (05) : 282 - 288
  • [9] Induction therapy for pediatric onset class IV lupus nephritis: Mycophenolate Mofetil versus Cyclophosphamide
    Marwa Chbihi
    Laurye-Anne Eveillard
    Quentin Riller
    Romain Brousse
    Romain Berthaud
    Pierre Quartier
    Rémi Salomon
    Marina Charbit
    Marina Avramescu
    Nathalie Biebuyck
    Laurène Dehoux
    Nicolas Garcelon
    Jean-Paul Duong-Van-Huyen
    Brigitte Bader-Meunier
    Olivia Boyer
    Journal of Nephrology, 2023, 36 : 829 - 839
  • [10] Induction therapy for pediatric onset class IV lupus nephritis: Mycophenolate Mofetil versus Cyclophosphamide
    Chbihi, Marwa
    Eveillard, Laurye-Anne
    Riller, Quentin
    Brousse, Romain
    Berthaud, Romain
    Quartier, Pierre
    Salomon, Remi
    Charbit, Marina
    Avramescu, Marina
    Biebuyck, Nathalie
    Dehoux, Laurene
    Garcelon, Nicolas
    Duong-Van-Huyen, Jean-Paul
    Bader-Meunier, Brigitte
    Boyer, Olivia
    JOURNAL OF NEPHROLOGY, 2023, 36 (03) : 829 - 839
12345